• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Kodak CAD nears market

Article

The FDA has issued an approvable letter for a mammography CAD device developed by Kodak. Approvable letters usually precede final FDA consent for marketing, provided certain criteria are met. Kodak plans to offer the CAD technology as a stand-alone

The FDA has issued an approvable letter for a mammography CAD device developed by Kodak. Approvable letters usually precede final FDA consent for marketing, provided certain criteria are met. Kodak plans to offer the CAD technology as a stand-alone product and as a component of its digital capture and image-and-information management systems. According to the company, clinical trial results submitted to the FDA suggest that 39.4% of missed breast cancers would be detected 14.8 months earlier if Kodak's new technology were used.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.